Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.499658
Title: Development, implementation and evaluation of an integrated follow-up programme for people with cutaneous malignant melanoma
Author: Murchie, Peter
Awarding Body: University of Aberdeen
Current Institution: University of Aberdeen
Date of Award: 2008
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Aim: To establish if GP-led integrated melanoma follow-up is feasible, and comparable to hospital-based follow-up, in terms of patient satisfaction, guideline adherence, quality of life and cost. Methods: Intervention design: GP-led integrated melanoma follow-up was designed and tested according to the MRC framework for the design and evaluation of complex healthcare interventions. Exploratory randomised trial: An exploratory randomised trial involving 35 practices and 142 patients was conducted to determine whether patients were more satisfied with the GP-led follow-up than hospital-based follow-up. The study also explored guideline adherence; health-related quality of life; and costs. Parallel qualitative interviews: Semi-structured interviews were conducted with 18 patient recipients and 17 intervention GPs, ascertaining their experiences and views of the new service. Results: A GP-led integrated melanoma follow-up is feasible. It was attractive to most patients eligible to receive it. Patients that received the programme reported better satisfaction with follow-up during the study year in 6 out of 15 aspects of follow-up care. Patients receiving GP-led follow-up were more likely to be seen within guidelines. The GP-led integrated melanoma follow-up did not adversely affect health-related quality of life. Integrated GP-led follow-up for cutaneous malignant was cheaper than traditional hospital follow-up. Most patients who received the integrated follow-up from their GP had positive opinions about it. Conclusions: GP-led integrated melanoma follow-up is feasible; satisfactory to most patients; facilitated guideline adherence; produced no deterioration in health related quality of life; was cheaper than traditional hospital-based follow-up; and viewed positively by patients and GPs. A full-scale randomised controlled trial of integrated GP-led melanoma follow-up is feasible.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.499658  DOI: Not available
Share: